Systems analysis of human vaccine adjuvants

被引:39
|
作者
Harandi, Ali M. [1 ]
机构
[1] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden
关键词
Vaccine; Adjuvant; Vaccinology; Systems vaccinology; Omics; Transcriptomics; MOLECULAR SIGNATURES; SEASONAL INFLUENZA; TUBERCULOSIS; IMMUNOGENICITY; INFLAMMASOME; RESPONSES; BIOLOGY; ALUM; MF59;
D O I
10.1016/j.smim.2018.08.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The discovery and wide spread use of vaccines have saved millions of lives in the past few decades. Vaccine adjuvants represent an integral part of the modem vaccines. Despite numerous efforts, however, only a handful of vaccine adjuvants is currently available for human use. A comprehensive understanding of the mechanisms of action of adjuvants is pivotal to harness the potential of existing and new adjuvants in mounting desirable immune responses to counter human pathogens. Decomposing the host response to vaccines and its components at systems level has recently been made possible owing to the recent advancements in Omics technology and cutting edge immunological assays powered by systems biology approaches. This approach has begun to shed light on the molecular signatures of several human vaccines and adjuvants. This review is an attempt to provide an overview of the recent efforts in systems analysis of vaccine adjuvants that are currently in clinic.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 50 条
  • [21] Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity
    Cao, Xuezhi
    Fu, Yang-Xin
    Peng, Hua
    VACCINES, 2024, 12 (05)
  • [22] Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine
    Akagi, Takami
    Baba, Masanori
    Akashi, Mitsuru
    POLYMERS IN NANOMEDICINE, 2012, 247 : 31 - 64
  • [23] Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations
    Perez, O.
    Batista-Duharte, A.
    Gonzalez, E.
    Zayas, C.
    Balboa, J.
    Cuello, M.
    Cabrera, O.
    Lastre, M.
    Schijns, V. E. J. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2012, 45 (08) : 681 - 692
  • [24] Vaccine adjuvants
    Blin, Aurore
    ACTUALITES PHARMACEUTIQUES, 2019, 58 (584): : 52 - 55
  • [25] Are we entering a new age for human vaccine adjuvants?
    O'Hagan, Derek T.
    Fox, Christopher B.
    EXPERT REVIEW OF VACCINES, 2015, 14 (07) : 909 - 911
  • [26] Evaluation of adjuvants for a candidate conjugate vaccine against benzo[a]pyrene
    Schellenberger, Mario T.
    Farinelle, Sophie
    Willieme, Stephanie
    Muller, Claude P.
    HUMAN VACCINES, 2011, 7 : 166 - 173
  • [27] Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants
    Wang, Pengfei
    Skalamera, Dani
    Sui, Xianwei
    Zhang, Ping
    Michalek, Suzanne M.
    ACS INFECTIOUS DISEASES, 2019, 5 (06): : 974 - 981
  • [28] Naturally occurring low biological reactivity lipopolysaccharides as vaccine adjuvants
    Darveau, Richard P.
    Chilton, Paula M.
    EXPERT REVIEW OF VACCINES, 2013, 12 (07) : 707 - 709
  • [29] TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
    Luchner, Marina
    Reinke, Soren
    Milicic, Anita
    PHARMACEUTICS, 2021, 13 (02) : 1 - 16
  • [30] Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants
    Akache, Bassel
    Stark, Felicity C.
    Iqbal, Umar
    Chen, Wangxue
    Jia, Yimei
    Krishnan, Lakshmi
    McCluskie, Michael J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (07) : 1746 - 1759